Most Recent

image: Capsule Reviews

Capsule Reviews

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

1 Comment

image: Contributors

Contributors

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Fungal Security Force

Fungal Security Force

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Keep Off the Grass

Keep Off the Grass

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Holding Their Ground

Holding Their Ground

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

1 Comment

image: Plant Immunity

Plant Immunity

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Infection-Autism Link Explained?

Infection-Autism Link Explained?

By | January 31, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Cross-Reactive Ebola Antibodies

Cross-Reactive Ebola Antibodies

By | January 21, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

image: Planning for the Next Ebola Outbreak

Planning for the Next Ebola Outbreak

By | January 20, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech